Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e232ad928e88547111ef87fba3dfa84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ee390e241e1ca7039fdcaddd555eb64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_209336c0b08bca409cc9946a8d675ede http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85e601a1bd5ad96356b2fd67a08287c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a959227af1fa9c8c7c71d78e7763f11e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
filingDate |
2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e8324dc3ff4dd774e9ec1bf621f5728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_066925b14457fca74099f6112cf2a1f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99cb5a22d943acf5a865d2360363ca77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbfacebf310c0e52218f56ea531de0a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b468b99e35bbdc796c389da5ba1cc309 |
publicationDate |
2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012309704-A1 |
titleOfInvention |
Compositions for treatment of chemoresistant and/or potentially chemoresistant leukaemias |
abstract |
This description applies to pharmaceutical compositions comprising a mixture comprising one or more hERG1 channel blockers in combination with one or more compounds for anticancer therapy for use in the treatment of chemoresistant or potentially chemoresistant leukaemias and in vitro systems for the screening of substances suitable for use in the treatment of chemoresistant or potentially chemoresistant leukaemias. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426413-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11304961-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766441-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071739-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537585-B2 |
priorityDate |
2009-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |